The Effects of Injected Vitamin D on Prognosis of Patients with Urosepsis

Abstract

The aim of this study was to evaluate the effect of prescribing vitamin D on improving the symptoms of patients diagnosed with urosepsis. The participants were randomly divided into two equal groups (each consisting of 50 patients). The patients in the first group received standard treatment with 300 000 units of injected vitamin with a volume of 1 cc. As for the patients in the second group, they received standard treatment along with 1 cc normal saline injected to them as placebo. Vital signs of the patients were checked every 6 h, while their CBC, EXR, CRP, creatinine, urea, and uric acid were checked 0, 24, 48, and 72 h following the interventions. Calcium, phosphorus, and vitamin D levels were measured 72 h following injection of the medicine. A significant difference was observed between the two groups in terms of the number of WBC’s in 24th, 48th, and 72nd hours. A similarly significant difference was reported between the case and control group in terms of the average BUN within 24th, 48th, and 72nd hours. The difference observed between the two groups in terms of average Cr within the 0th, 24th, 48th, and 72nd hours and in terms of days of hospitalization was also significant. Considering these results and keeping in mind the fact that no particular side effects were reported as a result of utilizing muscular injections of vitamin D and the easy and cheap use of this medicine, it can be used in auxiliary treatment of patients with urosepsis.

Key words

vitamin D - prognosis - urosepsis - patients

• References

• 1 Wagenlehner FM, Tandogdu Z, Bjerklund Johansen TE. An update on classification and management of urosepsis. Curr Opin Urol 2017; 27: 133-137
• 2 Angus DC, Van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369: 840-851
• 3 Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-1377
• 4 Schaub N, Frei R, Muller C. Addressing unmet clinical needs in the early diagnosis of sepsis. Swiss Med Wkly 2011; 141: w13244
• 5 Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138-150
• 6 Lee P, Eisman JA, Center JR. Vitamin D deficiency in critically ill patients. N Engl J Med 2009; 360: 1912-1914
• 7 Van den Berghe G, Van Roosbroeck D, Vanhove P, Wouters PJ, De Pourcq L, Bouillon R. Bone turnover in prolonged critical illness: Effect of vitamin D. J Clin Endocrinol Metab 2003; 88: 4623-4632
• 8 Darvishi M. Virulence Factors Profile and Antimicrobial Resistance of Acinetobacter baumannii Strains Isolated from Various Infections Recovered from Immunosuppressive Patients. Biomed Pharmacol J 2016; 9: 1057-1062
• 9 Jeng L, Yamshchikov AV, Judd SE, Blumberg HM, Martin GS, Ziegler TR. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009; 7: 2
• 10 Darvishi M. Antibiotic Resistance Pattern of Uropathogenic Methicillin-resistant Staphylococcus aureus Isolated from Immunosuppressive Patients with Pyelonephritis. J Pure Appl Micro 2016; 10: 2663-2667
• 11 Matthews LR, Ahmed Y, Wilson KL, Griggs DD, Danner OK. Worsening severity of vitamin D deficiency is associated with increased length of stay, surgical intensive care unit cost, and mortality rate in surgical intensive care unit patients. Am J Surg 2012; 204: 37-43
• 12 Allen AC, Kelly S, Basdeo SA, Kinsella K, Mulready KJ, Mills KH. A pilot study of the immunological effects of high-dose vitamin D in healthy volunteers. Mult Scler 2012; 18: 1797-1800
• 13 Cluse ZN, Fudge AN, Whiting MJ, McWhinney B, Parkinson I, O'Loughlin PD. Evaluation of 25-hydroxy vitamin D assay on the immunodiagnostic systems iSYS analyser. Ann Clin Bioch 2012; 49: 159-165
• 14 Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF. Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev 2008; 29: 726-776
• 15 Verstuyf A, Carmeliet G, Bouillon R, Mathieu C. Vitamin D: A pleiotropic hormone. Kid Intern 2010; 78: 140-145
• 16 Adams JS, Hewison M. Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nature Clin Prac Endo Met 2008; 4: 80-90
• 17 Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. Eur J Clin Nut 2012; 66: 1072-1074
• 18 De Haan K, Groeneveld AB, De Geus HR, Egal M, Struijs A. Vitamin D deficiency as a risk factor for infection, sepsis and mortality in the critically ill: Systematic review and meta-analysis. Crit Care 2014; 18: 660
• 19 Hewison M. Vitamin D and innate and adaptive immunity. Vit Horm 2011; 86: 23-62
• 20 Hewison M. Antibacterial effects of vitamin D. Nat Rev Endocrinol 2011; 7: 337-345
• 21 Segaert S, Shear NH, Chiricozzi A, Thaçi D, Carrascosa JM, Young H, Descamps V. Optimizing anti-inflammatory and immunomodulatory effects of corticosteroid and vitamin d analogue fixed-dose combination therapy. Dermatol Ther (Heidelberg) 2017; 7: 265-279
• 22 Lei GS, Zhang C, Zimmerman MK, Lee CH. Vitamin D as supplemental therapy for pneumocystis pneumonia. Antimicrob Agents Chemother 2015; 60: 1289-1297
• 23 Glück T. Vitamin D Deficiency and Risk for Sepsis. Crit Care Med 2013 Aug 26 [E-pub ahead of print]
• 24 Quan H, Sundararajan V, Halfon P. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005; 43: 1130-1139